Zydus starts phase 2 COVID-19 vaccine trial after clearing safety test Zydus Cadila has finished a phase 1 clinical trial of its COVID-19 vaccine ZyCoV-D, setting it up to move straight into a 1,000-subject phase 2 study. The Indian company informed that the DNA vaccine was well tolerated in the first stage of t...
Find MoreModerna Therapeutics has announced the positive results of trials of its COVID-19 vaccine, mRNA-1273. The results of interim Phase I clinical trial showed promising outcomes in terms of efficacy and tolerability and potential of mRNA-1273 against COVID-19. The company received the funds for conductin...
Find MoreThe American Society of Clinical Oncology is a platform that provides a global connection to researchers, pharma companies, and healthcare professions standing against cancer, finding a cure for it.